Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
This is a prospective, single site, randomized, double masked, comparator-controlled study designed to evaluate the efficacy of lifitegrast ophthalmic solution 5% in treating the symptoms of dry eye in soft contact lens wearers as compared to control. We hypothesize that there will be a significant improvement in dry eye symptoms in contact lens wearers using lifitegrast as compared to those being treated with control (lifitegrast vehicle).
Inclusion Criteria:
Subjects must read, understand and sign the Statement of Informed Consent
Subjects must be at least 18 years of age
Subjects must be habitual soft contact lens (CL) wearers, with a daily, weekly, bi- weekly or monthly replacement schedule
Habitual contact lenses must have a suitable fit as determined by the investigator
Subjects must report a history of dry eye symptoms, for which they have used rewetting drops or Artificial Tears (ATs) in the past 30 days
Subjects must be willing to discontinue the use of Artificial Tears (ATs) and rewetting drops for the duration of the study
Subjects must have a score of 12 or higher on the CLDEQ (Contact Lens Dry Eye Questionnaire-8) at baseline
Subjects must have at least 2 of the following signs of dry eye disease:
Subjects must be able to read at least half of the 20/25 (via entrance Snellen visual acuity) or better in each eye in their current contact lens prescription.
Subjects currently wearing reusable contact lenses must be willing to use Clear Care solution for cleaning and disinfecting throughout the study.
Exclusion Criteria: